TABLE 3.

Comparison of mean serum rK39AB titer (95% CI) different groups at different time points.

Time	TF (N = 7) (95% CI)	VLR (N = 10) (95% CI)	PKDL (N = 32) (95% CI)	VL control (N = 38) (95% CI)
Baseline	399,461@ (306,173–492,749)	878,968# (666,143–1,091,794)	1,558,044 (1,497,948–1,618,139)	1,456,777 (1,323,891–1,589,664)
Day 30	294,483@ (154,558–434,408)	1,103,701& (879,257–1,328,145)	1,516,932 (1,433,444–1,600,421)	1,400,044 (1,250,620–1,549,467)
Day 180	426,072@ (319,139–533,006)	1,256,668 (858,581–1,654,754)	1,299,201 (1,129,658–1,468,745)	1,039,447 (853,583–1,225,312)
Day 365	619,544@@ (224,207–1,014,880)	1,516,307 (1,370,435–1,662,180)	1,370,186∗∗ (1,205,538–1,534,834)	935,618 (777,604–1,093,632)

^@p < 0.01 compared to all other groups; ^#p < 0.001 compared to PKDL and Control; ^&p < 0.001 compared to PKDL; ^@@p = 0.001 compared to VLR & PKDL; ^∗∗p = 0.001 compared to control.